Journal of the National Cancer Institute, ISSN 0027-8874, 05/2006, Volume 98, Issue 10, pp. 708 - 714
This is an updated systematic review of 57 trials and 9353 cancer patients from articles, abstracts, and reports published between January 1, 1985, and April...
PHASE-III TRIAL | MULTIPLE-MYELOMA | ONCOLOGY | PLATINUM-BASED CHEMOTHERAPY | DOUBLE-BLIND | NON-HODGKINS-LYMPHOMA | PLACEBO-CONTROLLED TRIAL | QUALITY-OF-LIFE | EPOETIN-ALPHA | PATIENTS RECEIVING CHEMOTHERAPY | DARBEPOETIN-ALPHA | Anemia, Hypochromic - drug therapy | Anemia, Hypochromic - prevention & control | Hematinics - therapeutic use | Risk Assessment | Thromboembolism - chemically induced | Erythrocyte Transfusion | Erythropoietin - therapeutic use | Humans | Treatment Outcome | Antineoplastic Agents - administration & dosage | Recombinant Proteins | Thromboembolism - epidemiology | Anemia, Hypochromic - therapy | Incidence | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Erythropoietin - analogs & derivatives | Antineoplastic Agents - adverse effects | Anemia, Hypochromic - chemically induced | Epoetin Alfa | Darbepoetin alfa | Research Design | Case studies | Cancer patients | Usage | Drug therapy | Health aspects | Erythropoietin, Recombinant | Cancer
PHASE-III TRIAL | MULTIPLE-MYELOMA | ONCOLOGY | PLATINUM-BASED CHEMOTHERAPY | DOUBLE-BLIND | NON-HODGKINS-LYMPHOMA | PLACEBO-CONTROLLED TRIAL | QUALITY-OF-LIFE | EPOETIN-ALPHA | PATIENTS RECEIVING CHEMOTHERAPY | DARBEPOETIN-ALPHA | Anemia, Hypochromic - drug therapy | Anemia, Hypochromic - prevention & control | Hematinics - therapeutic use | Risk Assessment | Thromboembolism - chemically induced | Erythrocyte Transfusion | Erythropoietin - therapeutic use | Humans | Treatment Outcome | Antineoplastic Agents - administration & dosage | Recombinant Proteins | Thromboembolism - epidemiology | Anemia, Hypochromic - therapy | Incidence | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Erythropoietin - analogs & derivatives | Antineoplastic Agents - adverse effects | Anemia, Hypochromic - chemically induced | Epoetin Alfa | Darbepoetin alfa | Research Design | Case studies | Cancer patients | Usage | Drug therapy | Health aspects | Erythropoietin, Recombinant | Cancer
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2005, Volume 97, Issue 7, pp. 489 - 498
Background: Anemia associated with cancer and cancer therapy is an important clinical and economic factor in the treatment of malignant diseases. Methods: We...
MULTIPLE-MYELOMA | CHEMOTHERAPY-INDUCED ANEMIA | ONCOLOGY | PLATINUM-BASED CHEMOTHERAPY | DOUBLE-BLIND | RECEPTOR EXPRESSION | NON-HODGKINS-LYMPHOMA | RANDOMIZED-TRIAL | QUALITY-OF-LIFE | EPOETIN-ALPHA | RED-CELL APLASIA | Erythropoietin - administration & dosage | Hematinics - therapeutic use | Risk Assessment | Erythropoietin - therapeutic use | Humans | Erythropoietin - adverse effects | Anemia - prevention & control | Anemia - therapy | Hematinics - adverse effects | Treatment Outcome | Recombinant Proteins | Blood Transfusion - statistics & numerical data | Hematinics - administration & dosage | Randomized Controlled Trials as Topic | Neoplasms - therapy | Survival Analysis | Anemia - etiology | Prevention | Cancer patients | Care and treatment | Erythropoietin | Anemia | Patient outcomes | Drug therapy
MULTIPLE-MYELOMA | CHEMOTHERAPY-INDUCED ANEMIA | ONCOLOGY | PLATINUM-BASED CHEMOTHERAPY | DOUBLE-BLIND | RECEPTOR EXPRESSION | NON-HODGKINS-LYMPHOMA | RANDOMIZED-TRIAL | QUALITY-OF-LIFE | EPOETIN-ALPHA | RED-CELL APLASIA | Erythropoietin - administration & dosage | Hematinics - therapeutic use | Risk Assessment | Erythropoietin - therapeutic use | Humans | Erythropoietin - adverse effects | Anemia - prevention & control | Anemia - therapy | Hematinics - adverse effects | Treatment Outcome | Recombinant Proteins | Blood Transfusion - statistics & numerical data | Hematinics - administration & dosage | Randomized Controlled Trials as Topic | Neoplasms - therapy | Survival Analysis | Anemia - etiology | Prevention | Cancer patients | Care and treatment | Erythropoietin | Anemia | Patient outcomes | Drug therapy
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2005, Volume 97, Issue 7, p. 489
Background: Anemia associated with cancer and cancer therapy is an important clinical and economic factor in the treatment of malignant diseases. Methods: We...
Survival analysis | Anemia | Hormones | Cancer
Survival analysis | Anemia | Hormones | Cancer
Journal Article
Best Practice & Research Clinical Haematology, ISSN 1521-6926, 2005, Volume 18, Issue 3, pp. 449 - 454
Cancer and cancer therapy-associated anemia may have an impact on tumor response and overall survival. Additionally, anemia represents an important economic...
recombinant human erythropoietin | systematic review | cancer therapy | Recombinant human erythropoietin | Systematic review | Cancer therapy | TRIALS | EPOETIN | METAANALYSES | ANEMIA | HEMATOLOGY | CANCER | Multicenter Studies as Topic - statistics & numerical data | Meta-Analysis as Topic | Randomized Controlled Trials as Topic - statistics & numerical data | Erythropoietin - therapeutic use | United States | Europe | Humans | Databases, Factual - statistics & numerical data | Erythropoietin - adverse effects | Anemia - prevention & control | Recombinant Proteins | Erythrocyte Transfusion - methods | Neoplasms - complications | Anemia - drug therapy | Decision Trees | Care and treatment | Erythropoietin | Anemia | Analysis | Hemoglobin | Growth factors | Cancer
recombinant human erythropoietin | systematic review | cancer therapy | Recombinant human erythropoietin | Systematic review | Cancer therapy | TRIALS | EPOETIN | METAANALYSES | ANEMIA | HEMATOLOGY | CANCER | Multicenter Studies as Topic - statistics & numerical data | Meta-Analysis as Topic | Randomized Controlled Trials as Topic - statistics & numerical data | Erythropoietin - therapeutic use | United States | Europe | Humans | Databases, Factual - statistics & numerical data | Erythropoietin - adverse effects | Anemia - prevention & control | Recombinant Proteins | Erythrocyte Transfusion - methods | Neoplasms - complications | Anemia - drug therapy | Decision Trees | Care and treatment | Erythropoietin | Anemia | Analysis | Hemoglobin | Growth factors | Cancer
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 05/2006, Volume 98, Issue 10, p. 708
This is an updated systematic review of 57 trials and 9353 cancer patients from articles, abstracts, and reports published between January 1, 1985, and April...
Side effects | Clinical trials | Comparative analysis | Cancer | Meta-analysis
Side effects | Clinical trials | Comparative analysis | Cancer | Meta-analysis
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 05/2006, Volume 98, Issue 10, pp. 708 - 714
This is an updated systematic review of 57 trials and 9353 cancer patients from articles, abstracts, and reports published between January 1, 1985, and April...
Journal Article
Universiẗat, Diss--Köln, 2004.
Dissertation
1980, Philologische Studien und Quellen, ISBN 9783503016402, Volume Heft 102, 262
Book
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.